These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 21226903)

  • 21. Expression of NDRG2 in esophageal squamous cell carcinoma.
    Shi H; Li N; Li S; Chen C; Wang W; Xu C; Zhang J; Jin H; Zhang H; Zhao H; Song W; Feng Q; Feng X; Shen X; Yao L; Zhao Q
    Cancer Sci; 2010 May; 101(5):1292-9. PubMed ID: 20331630
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epigenetic silencing of NDRG2 promotes colorectal cancer proliferation and invasion.
    Hong SN; Kim SJ; Kim ER; Chang DK; Kim YH
    J Gastroenterol Hepatol; 2016 Jan; 31(1):164-71. PubMed ID: 26250123
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prediction of colorectal cancer relapse and prognosis by tissue mRNA levels of NDRG2.
    Chu D; Zhang Z; Li Y; Wu L; Zhang J; Wang W; Zhang J
    Mol Cancer Ther; 2011 Jan; 10(1):47-56. PubMed ID: 21220491
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tissue array for Tp53, C-myc, CCND1 gene over-expression in different tumors.
    Liu GY; Luo Q; Xiong B; Pan C; Yin P; Liao HF; Zhuang WC; Gao HZ
    World J Gastroenterol; 2008 Dec; 14(47):7199-207. PubMed ID: 19084934
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NDRG2 acts as a negative regulator downstream of androgen receptor and inhibits the growth of androgen-dependent and castration-resistant prostate cancer.
    Yu C; Wu G; Li R; Gao L; Yang F; Zhao Y; Zhang J; Zhang R; Zhang J; Yao L; Yuan J; Li X
    Cancer Biol Ther; 2015; 16(2):287-96. PubMed ID: 25756511
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor suppressor candidate gene, NDRG2 is frequently inactivated in human glioblastoma multiforme.
    Zhou B; Tang Z; Deng Y; Hou S; Liu N; Lin W; Liu X; Yao L
    Mol Med Rep; 2014 Aug; 10(2):891-6. PubMed ID: 24840052
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of human NDRG2 by myeloid dendritic cells inhibits down-regulation of activated leukocyte cell adhesion molecule (ALCAM) and contributes to maintenance of T cell stimulatory activity.
    Choi SC; Kim KD; Kim JT; Kim JW; Lee HG; Kim JM; Jang YS; Yoon DY; Kim KI; Yang Y; Cho DH; Lim JS
    J Leukoc Biol; 2008 Jan; 83(1):89-98. PubMed ID: 17911180
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Down-regulation of NDRG2 gene expression in human colorectal cancer involves promoter methylation and microRNA-650.
    Feng L; Xie Y; Zhang H; Wu Y
    Biochem Biophys Res Commun; 2011 Mar; 406(4):534-8. PubMed ID: 21352815
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Identification of the differentially expressed genes between primary breast cancer and paired lymph node metastasis through combining mRNA differential display and gene microarray].
    Feng YM; Gao G; Zhang F; Chen H; Wan YF; Li XQ
    Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(39):2749-55. PubMed ID: 17199993
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of NDRG2 in human lung cancer and its correlation with prognosis.
    Li SJ; Wang WY; Li B; Chen B; Zhang B; Wang X; Chen CS; Zhao QC; Shi H; Yao L
    Med Oncol; 2013 Mar; 30(1):421. PubMed ID: 23307246
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intelectin 1 suppresses the growth, invasion and metastasis of neuroblastoma cells through up-regulation of N-myc downstream regulated gene 2.
    Li D; Mei H; Pu J; Xiang X; Zhao X; Qu H; Huang K; Zheng L; Tong Q
    Mol Cancer; 2015 Feb; 14():47. PubMed ID: 25889839
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Expression and significance of new candidate tumor suppressor gene N-Myc downstream-regulated gene 2 in colorectal cancer].
    Shi H; Wang WZ; Yao LB; Zhang J; Yin Q; Xu CS; Chu DK; Dong GL; Zhang HW; Li JP
    Zhonghua Wei Chang Wai Ke Za Zhi; 2009 May; 12(3):281-4. PubMed ID: 19434539
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined aberrant expression of N-Myc downstream-regulated gene 2 and CD24 is associated with disease-free survival and overall survival in patients with hepatocellular carcinoma.
    Li B; Shao Q; Ji D; Li F; Guo X; Chen G
    Diagn Pathol; 2014 Oct; 9():209. PubMed ID: 25338637
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Frequent promoter hypermethylation and transcriptional downregulation of the NDRG2 gene at 14q11.2 in primary glioblastoma.
    Tepel M; Roerig P; Wolter M; Gutmann DH; Perry A; Reifenberger G; Riemenschneider MJ
    Int J Cancer; 2008 Nov; 123(9):2080-6. PubMed ID: 18709645
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NDRG2, suppressed expression associates with poor prognosis in pancreatic cancer, is hypermethylated in the second promoter in human gastrointestinal cancers.
    Yamamura A; Miura K; Karasawa H; Motoi F; Mizuguchi Y; Saiki Y; Fukushige S; Sunamura M; Shibata C; Unno M; Horii A
    Biochem Biophys Res Commun; 2017 Feb; 484(1):138-143. PubMed ID: 28093228
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of BMI-1 and Mel-18 in breast tissue--a diagnostic marker in patients with breast cancer.
    Riis ML; Lüders T; Nesbakken AJ; Vollan HS; Kristensen V; Bukholm IR
    BMC Cancer; 2010 Dec; 10():686. PubMed ID: 21162745
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor grade-related NDRG2 gene expression in primary and recurrent intracranial meningiomas.
    Skiriute D; Tamasauskas S; Asmoniene V; Saferis V; Skauminas K; Deltuva V; Tamasauskas A
    J Neurooncol; 2011 Mar; 102(1):89-94. PubMed ID: 20607352
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NDRG2 expression and mutation in human liver and pancreatic cancers.
    Hu XL; Liu XP; Lin SX; Deng YC; Liu N; Li X; Yao LB
    World J Gastroenterol; 2004 Dec; 10(23):3518-21. PubMed ID: 15526377
    [TBL] [Abstract][Full Text] [Related]  

  • 39. AKT-1, -2, and -3 are expressed in both normal and tumor tissues of the lung, breast, prostate, and colon.
    Zinda MJ; Johnson MA; Paul JD; Horn C; Konicek BW; Lu ZH; Sandusky G; Thomas JE; Neubauer BL; Lai MT; Graff JR
    Clin Cancer Res; 2001 Aug; 7(8):2475-9. PubMed ID: 11489829
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of N-myc downstream-regulated gene 2 in prostatic carcinoma.
    Yu C; Wu G; Dang N; Zhang W; Zhang R; Yan W; Zhao Y; Gao L; Wang Y; Beckwith N; Yuan J; Yao L
    Cancer Biol Ther; 2011 Aug; 12(4):304-13. PubMed ID: 21623166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.